R Fitzpatrick
Impact in
-
- Biosimilars and Bioanalytical Methods
Papers in
-
- Biosimilars and Bioanalytical Methods 8
-
- Pharmaceutical Economics and Policy 3
- Co-authors
- Stephen Chapman (10 shared papers)G N Volans (2 shared papers)Ian Smith (1 shared paper)Ian Jackson (1 shared paper)Mary Minton (1 shared paper)Louise Jones (1 shared paper)Nenad Miljković (2 shared papers)Jonathan Underhill (2 shared papers)
- Journals
- BMJ Open (4 papers)Journal of Evaluation in Clinical Practice (2 papers)BioDrugs (2 papers)International Journal of Pharmacy Practice (2 papers)Journal of Pharmaceutical and Biomedical Analysis (1 paper)
- Partner nations
- United KingdomIraqPortugal
In The Last Decade
R Fitzpatrick
29 papers receiving 435 citations
Peers
Comparison fields: 5 of 85
- Immunology 176
- Applied Microbiology and Biotechnology 12
- Geriatrics and Gerontology 15
- Medical Terminology 1
- Economics and Econometrics 91
Countries citing papers authored by R Fitzpatrick
This map shows the geographic impact of R Fitzpatrick's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R Fitzpatrick with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R Fitzpatrick more than expected).
Fields of papers citing papers by R Fitzpatrick
This network shows the impact of papers produced by R Fitzpatrick. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R Fitzpatrick. The network helps show where R Fitzpatrick may publish in the future.
Co-authors
The 24 scholars most cited alongside R Fitzpatrick, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 29 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Patients with cancer holding their own records: a randomised controlled trial. | 2000 | 47 |
| 2 | Ibuprofen toxicity. A review of adverse reactions and overdose. | 1993 | 47 |
| 3 | 2017 | 42 | |
| 4 | 2017 | 42 | |
| 5 | 2006 | 41 | |
| 6 | 2018 | 38 | |
| 7 | 2019 | 38 | |
| 8 | 2018 | 36 | |
| 9 | 2017 | 24 | |
| 10 | 2018 | 19 | |
| 11 | 1988 | 14 | |
| 12 | A STRUCTURED REVIEW OF PATIENT-REPORTED OUTCOME MEASURES (PROMs) FOR HEART FAILURE | 2009 | 10 |
| 13 | 2007 | 7 | |
| 14 | 1996 | 6 | |
| 15 | 2015 | 6 | |
| 16 | 2019 | 5 | |
| 17 | 2017 | 5 | |
| 18 | 2017 | 5 | |
| 19 | A STRUCTURED REVIEW OF PATIENT-REPORTED OUTCOME MEASURES (PROMs) FOR PROSTATE CANCER | 2009 | 5 |
| 20 | 2024 | 4 |
About R Fitzpatrick
R Fitzpatrick is a scholar working on Immunology, Economics and Econometrics, General Health Professions, Pharmacology and Surgery, having authored 29 papers that have together received 459 indexed citations. Recurring topics across this work include Biosimilars and Bioanalytical Methods (8 papers), Pharmaceutical Economics and Policy (3 papers), Patient Satisfaction in Healthcare (2 papers), Drug-Induced Hepatotoxicity and Protection (2 papers), Thermal Regulation in Medicine (2 papers), Patient Safety and Medication Errors (1 paper), Nausea and vomiting management (1 paper) and Cardiac, Anesthesia and Surgical Outcomes (1 paper). The work is most often cited by research in Immunology (176 citations), Applied Microbiology and Biotechnology (12 citations), Geriatrics and Gerontology (15 citations), Medical Terminology (1 citation) and Economics and Econometrics (91 citations). R Fitzpatrick has collaborated with scholars based in United Kingdom, Iraq and Portugal. Frequent co-authors include Stephen Chapman, G N Volans, Ian Smith, Ian Jackson, Mary Minton, Louise Jones, Nenad Miljković, Jonathan Underhill, M. I. Drury and P Yudkin. Their work appears in journals such as BMJ Open, Journal of Evaluation in Clinical Practice, BioDrugs, International Journal of Pharmacy Practice and Journal of Pharmaceutical and Biomedical Analysis.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.